Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Lycopene in Treating Patients With Metastatic Prostate Cancer
A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation
Status: Enrolling
Updated:  7/12/2016
1263
mi
from 98109
Sioux Falls, SD
Lycopene in Treating Patients With Metastatic Prostate Cancer
A Phase II Trial Of Lycopene For Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer With PSA Elevation
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
1263
mi
from 98109
Sioux Falls, SD
Click here to add this to my saved trials
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
A Phase III Randomized Prospective Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
Status: Enrolling
Updated:  7/13/2016
1892
mi
from 98109
Houston, TX
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
A Phase III Randomized Prospective Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
Status: Enrolling
Updated: 7/13/2016
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors
Status: Enrolling
Updated:  7/25/2016
2110
mi
from 98109
Buffalo, NY
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
A Phase I Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced Anti-tumor Immunity in Patients With NY-ESO-1 Expressing Solid Tumors
Status: Enrolling
Updated: 7/25/2016
Roswell Park Cancer Institute
2110
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Status: Enrolling
Updated:  7/25/2016
2161
mi
from 98109
Rochester, NY
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Status: Enrolling
Updated: 7/25/2016
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
For Cause Prostate Biopsy in REDUCE Population Trial
Determining the Likelihood of Prostate Cancer Detection in Men Taking Dutasteride When Biopsy is Performed 'for Cause'.
Status: Enrolling
Updated:  8/9/2016
2024
mi
from 98109
Cleveland, OH
For Cause Prostate Biopsy in REDUCE Population Trial
Determining the Likelihood of Prostate Cancer Detection in Men Taking Dutasteride When Biopsy is Performed 'for Cause'.
Status: Enrolling
Updated: 8/9/2016
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Neoadjuvant Ipilimumab in Prostate Cancer
A Neoadjuvant Phase IIa Study of Ipilimumab {Formerly Known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men With Prostate Cancer Followed by Radical Prostatectomy.
Status: Enrolling
Updated:  8/18/2016
1892
mi
from 98109
Houston, TX
Neoadjuvant Ipilimumab in Prostate Cancer
A Neoadjuvant Phase IIa Study of Ipilimumab {Formerly Known as MDX-010 (BMS-734016)} Plus Hormone Ablation in Men With Prostate Cancer Followed by Radical Prostatectomy.
Status: Enrolling
Updated: 8/18/2016
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated:  11/28/2016
149
mi
from 98109
Portland, OR
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated: 11/28/2016
Portland VA Medical Center
149
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated:  11/28/2016
146
mi
from 98109
Portland, OR
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Status: Enrolling
Updated: 11/28/2016
Oregon Health & Science University Advanced Imaging Research Center
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1429
mi
from 98109
Anchorage, AK
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1429
mi
from 98109
Anchorage, AK
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1112
mi
from 98109
Phoenix, AZ
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1779
mi
from 98109
Little Rock, AR
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1779
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
981
mi
from 98109
Anaheim, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
981
mi
from 98109
Anaheim, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1063
mi
from 98109
La Mesa, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1063
mi
from 98109
La Mesa, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
999
mi
from 98109
Laguna Hills, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
999
mi
from 98109
Laguna Hills, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
960
mi
from 98109
Los Angeles, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
960
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1050
mi
from 98109
Poway, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1050
mi
from 98109
Poway, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
970
mi
from 98109
San Bernardino, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
970
mi
from 98109
San Bernardino, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1058
mi
from 98109
San Diego, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1058
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
951
mi
from 98109
Tarzana, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
951
mi
from 98109
Tarzana, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
976
mi
from 98109
Torrance, CA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
976
mi
from 98109
Torrance, CA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1022
mi
from 98109
Denver, CO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1022
mi
from 98109
Denver, CO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1024
mi
from 98109
Englewood, CO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1024
mi
from 98109
Englewood, CO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
997
mi
from 98109
Longmont, CO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
997
mi
from 98109
Longmont, CO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2427
mi
from 98109
New Britain, CT
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2427
mi
from 98109
New Britain, CT
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2322
mi
from 98109
Washington,
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2226
mi
from 98109
Longwood, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2226
mi
from 98109
Longwood, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2549
mi
from 98109
Orlando, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2549
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2519
mi
from 98109
Panellas Park, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2519
mi
from 98109
Panellas Park, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2732
mi
from 98109
Pinecrest, FL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2732
mi
from 98109
Pinecrest, FL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
258
mi
from 98109
Coeur d'Alene, ID
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
258
mi
from 98109
Coeur d'Alene, ID
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1634
mi
from 98109
Galesburg, IL
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1634
mi
from 98109
Galesburg, IL
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1872
mi
from 98109
Fort Wayne, IN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1872
mi
from 98109
Fort Wayne, IN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1875
mi
from 98109
Greenwood, IN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1875
mi
from 98109
Greenwood, IN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1939
mi
from 98109
Jeffersonville, IN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1939
mi
from 98109
Jeffersonville, IN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1504
mi
from 98109
Overland Park, KA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1504
mi
from 98109
Overland Park, KA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1440
mi
from 98109
Wichita, KA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1440
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2344
mi
from 98109
Annapolis, MD
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2344
mi
from 98109
Annapolis, MD
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2323
mi
from 98109
Towson, MD
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2323
mi
from 98109
Towson, MD
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2485
mi
from 98109
Boston, MA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2479
mi
from 98109
Watertown, MA
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2479
mi
from 98109
Watertown, MA
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1922
mi
from 98109
Royal Oak, MI
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1922
mi
from 98109
Royal Oak, MI
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1780
mi
from 98109
St. Joseph, MI
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1780
mi
from 98109
St. Joseph, MI
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1379
mi
from 98109
Chaska, MN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1379
mi
from 98109
Chaska, MN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1334
mi
from 98109
Sartell, MN
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1334
mi
from 98109
Sartell, MN
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1506
mi
from 98109
Kansas City, MO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1506
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1634
mi
from 98109
Springfield, MO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1634
mi
from 98109
Springfield, MO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1718
mi
from 98109
St. Louis, MO
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1718
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
1365
mi
from 98109
Omaha, NE
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
1365
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2388
mi
from 98109
West Orange, NJ
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2388
mi
from 98109
West Orange, NJ
Click here to add this to my saved trials
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated:  11/30/2016
2351
mi
from 98109
Albany, NY
ARI103094-Follow-Up Study for REDUCE Study Subjects
ARI103094-Follow-Up Study for REDUCE Study Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
2351
mi
from 98109
Albany, NY
Click here to add this to my saved trials